A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control

• Status: Completed
• Trial end date: 2012-05-29
• Target enrollment: 0
• Participant gender: All

Summary

The purposes of this study are:

• to investigate the extent of cardiovascular complications in a representative cohort (n=135) of adult patients with type 2 diabetes;

• to examine if modern non-invasive assessment can replace invasive assessment;

• to determine the effects of a 6 month lifestyle interventional program on weight, glycemic control and lipids in 60 patients;

• to determine the effect of a 2-year prospective, randomised multi-interventional program (n=120) on cardiovascular risk, anthropometric measures and glycometabolic control; and

• to investigate inflammatory markers in this setting.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Asker & Baerum Hospital
• Collaborators: Rikshospitalet University Hospital; Sahlgrenska University Hospital, Sweden; University Hospital, Aker
• Treatments: Metformin

Criteria

Inclusion Criteria:

• Type 2 diabetes

• Ages 18-75 years

• Men and women

• At least one cardiovascular risk factor (i.e hypertension, dyslipidemia, smoking/formerly smoker, premature familial coronary artery disease [CAD], microalbuminuria)

• Written informed consent given

Exclusion Criteria:

• Unwillingness

• Age < 18 or > 75 years

• Unstable cardiovascular condition

• Unstable medical condition